Decline of serum albumin precedes severe acute GVHD after haploidentical HSCT
Sign Up to like & getrecommendations! Published in 2020 at "Pediatrics International"
DOI: 10.1111/ped.14564
Abstract: Background: Haploidentical hematopoietic stem cell transplantation (HSCT) is a useful therapy for relapsed/refractory acute leukemia or lymphoma because of the strong graft‐vs‐leukemia (GVL) effect. However, it is often accompanied by severe acute graft‐versus‐host disease (aGVHD),… read more here.
Keywords: severe acute; haploidentical hsct; decline serum; albumin precedes ... See more keywords
Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide.
Sign Up to like & getrecommendations! Published in 2017 at "Blood advances"
DOI: 10.1182/bloodadvances.2017009423
Abstract: The establishment of safe approaches to attain durable donor-type chimerism and immune tolerance toward donor antigens represents a major challenge in transplantation biology. Haploidentical hematopoietic stem cell transplantation (HSCT) is currently used for cancer therapy… read more here.
Keywords: posttransplant cyclophosphamide; haploidentical hsct; immune tolerance; hsct ... See more keywords